Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

CAS No. :	51037-30-0
Formula :	C₆H₆N₂O₃
M.W :	154.12
SMILES Code :	O=C(C1=C[N+]([O-])=C(C)C=N1)O
Synonyms :	K-9321
MDL No. :	MFCD00865757
InChI Key :	DJQOOSBJCLSSEY-UHFFFAOYSA-N
Pubchem ID :	5310993

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H319
Precautionary Statements:	P305+P351+P338

Patients with non-insulin-dependent diabetes mellitus	Human patients	Oral	2×250 mg	Single dose, experiment lasted approximately 6 hours	To study the effect of Acipimox on glucose metabolism under basal and insulin-stimulated conditions. Results showed that Acipimox reduced NEFA levels in both basal and insulin-stimulated states, inhibited lipid oxidation, increased insulin-stimulated glucose disposal rate, and enhanced basal and insulin-stimulated muscle glycogen synthase activity.	PMC295597
C57BL/6 mice	High-methionine diet-induced hyperhomocysteinemia model	Oral	0.08 g/kg	Once daily for 8 weeks	To evaluate the effect of Acipimox on Hcy-induced lipolysis and nonalcoholic fatty liver, results showed that Acipimox significantly reduced Hcy-induced lipolysis and hepatic lipid accumulation	PMC7559542
LDLR null mice	Atherosclerosis model	Oral administration in drinking water	0.05% wt	14 weeks	Evaluate the effect of Acipimox on ritonavir-induced atherosclerosis, results showed Acipimox reversed the adverse effects of ritonavir	PMC2783673
C57BL6/J mice	Intermittent hypoxia model	Drinking water	0.5 mg/ml	14 days	To investigate the effect of acipimox on glucose tolerance and insulin sensitivity in mice exposed to intermittent hypoxia, results showed that acipimox fully prevented IH-induced impairments in fasting glycemia, glucose tolerance, and insulin sensitivity.	PMC4979366
Nude mice	Prostate cancer xenograft model	Oral gavage	50 mg/kg	Single dose, 1 hour before tracer injection	In PC3 xenografts, Acipimox significantly increased tumor uptake of 18F-FDG and improved tumor-to-background ratios; no significant effect was observed in CWR22R v1 xenografts.	PMC3662867
C57BL/6J mice	High-fat diet-induced obesity model	Drinking water	0.05%	12 weeks	To study the effects of acipimox on e-cigarette-induced cardiac dysfunction. Results showed that acipimox reversed the e-cigarette-induced decrease in cardiac systolic function, increased levels of inflammatory cytokines and free fatty acids (FFAs), oxidative stress, and DNA damage.	PMC10600141

NCT01299831	Healthy	Not Applicable	Completed	-	Denmark ... More >> Department of medical endocrinology, University Hospital of Aarhus Aarhus, Denmark, 8000 Less <<
NCT01752348	Systemic Inflammatory Response... More >> Syndrome Less <<	Not Applicable	Completed	-	Denmark ... More >> Medical Research Laboratory, Department of Internal Medicine and Endocrinology Aarhus C, Denmark, 8000 Less <<
NCT00449423	Acute Heart Failure	Phase 2	Terminated(due to slow recruit... More >>ment) Less <<	-	Denmark ... More >> Aarhus University Hospital, Skejby Sygehus, Department of Cardiology Aarhus, Denmark, 8200 Less <<
NCT02792621	Impaired Mitochondrial Functio... More >>n, Muscle Performance Less <<	Not Applicable	Recruiting	December 8, 2018	United Kingdom ... More >> NIHR Exeter Clinical Research Facility Recruiting Exeter, Devon, United Kingdom, EX2 5DW Contact: Anna Steele, PhD 01392 408173 anna.steele@nhs.net Contact: Kim Rownden 01392 408188 kim.rowden@nhs.net Less <<
NCT03325491	Impaired Mitochondrial Functio... More >>n, Muscle Performance Less <<	Not Applicable	Recruiting	December 31, 2018	United Kingdom ... More >> NIHR Exeter Clinical Research Facility Recruiting Exeter, Devon, United Kingdom, EX2 5DW Contact: Colleen Deane, PhD 01392722882 c.s.deane@exeter.ac.uk Less <<
NCT01209416	Metabolism In... More >>sulin Resistance Hypopituitarism Less <<	Not Applicable	Completed	-	Denmark ... More >> University Hospital of Aarhus Aarhus, Denmark, 8000 Less <<
NCT00759291	Metabolic Syndrome	Phase 2 Phase 3	Completed	-	United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT02256722	Healthy	Phase 1	Completed	-	-
NCT02782208	Hypopituitarism ... More >> Insulin Resistance Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Pituitary Diseases Brain Diseases Less <<	Not Applicable	Unknown	November 2018	Denmark ... More >> University Hospital of Aarhus Recruiting Aarhus, Denmark, 8000 Contact: Astrid J Hjelholt, MD +4524800664 ajh@clin.au.dk Less <<
NCT00153179	Type 2 Diabetes Mellitus	Phase 1 Phase 2	Completed	-	United States, Massachusetts ... More >> Brigham & Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT00153179	-		Completed	-	-
NCT00246402	Insulin Resistance ... More >> Cardiovascular Diseases Heart Diseases HIV Infections Hypertriglyceridemia Hyperlipidemia Less <<	Not Applicable	Completed	-	United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00549614	Heart Failure	Not Applicable	Completed	-	Denmark ... More >> Department of Cardiology, Aarhus Universityhospital, Skejby Aarhus N, Denmark, 8200 Less <<
NCT01980524	Type 2 Diabetes	Phase 2 Phase 3	Completed	-	Austria ... More >> Division of Endocrinology and Metabolism, Internal Medicine III, Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT01980524	-		Completed	-	-
NCT01260376	Diabetes Obes... More >>ity Less <<	Not Applicable	Completed	-	Denmark ... More >> University Hospital of Aarhus, Norrebrogade Aarhus, Denmark, 8000 University Hospital of Aarhus, Norrebrogade Aarhus, Denmark, 8 Less <<
NCT01580813	Type 2 Diabetes	Not Applicable	Recruiting	December 2018	United States, Colorado ... More >> University of Colorado Anschutz Medical Campus Recruiting Aurora, Colorado, United States, 80045 Principal Investigator: Irene Schauer, MD, PhD Less <<
NCT01488409	Abdominal Obesity ... More >> Insulin Resistance Hypertriglyceridemia Less <<	Phase 2	Completed	-	United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT01488409	-		Completed	-	-
NCT01816165	Type 1 Diabetes	Phase 3	Active, not recruiting	September 2018	United States, Colorado ... More >> University of Colorado Denver Aurora, Colorado, United States, 80045 Less <<
NCT00943059	Diabetes Mellitus, Type 2 ... More >> Cardiomyopathy, Dilated Less <<	Not Applicable	Completed	-	Netherlands ... More >> Maastricht University Medical Centre Maastricht, Netherlands, 6200MD Less <<
NCT03338387	Eating Disorder ... More >> Bulimia Nervosa Less <<	Phase 2	Enrolling by invitation	August 1, 2018	-
NCT02796950	Diabetes Mellitus Type 2	Not Applicable	Completed	-	Denmark ... More >> University Hospital of Aarhus Aarhus, Denmark, 8000 Less <<

{[proInfo.proName]}

CAS No.: 51037-30-0

{[proInfo.proName]}

CAS No.: 51037-30-0

Alternative Products

Product Details of Acipimox

Safety of Acipimox

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

Bio Calculators
Preparing Stock Solutions		1mg	5mg	10mg
Preparing Stock Solutions	1 mM 5 mM 10 mM	6.49mL 1.30mL 0.65mL	32.44mL 6.49mL 3.24mL	64.88mL 12.98mL 6.49mL
Dissolving Methods	Animal experiment Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn: in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Protocol 1 Protocol 2 The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Protocol 1

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed